ESR 1
Integrated liquid biopsy for cancer diagnostics via genomic markers detection
University of Parma (Italy)
ESR 2
Point-of-care Raman microspectroscopy for detecting tumour markers in body liquids
Friedrich-Schiller University Jena (Germany)
ESR 3
Spectral tissue imaging for ex-vivo cancer diagnosis and survey
HORIBA FRANCE SAS, Villeneuve d’Ascq (France)
ESR 4
Integrated optical fibre sensors for intravital monitoring
Politecnico di Torino (Italy)
ESR 5
Hybrid diffuse optical monitoring and theranostics with blood flow and oxygen metabolism biomarkers on pre-clinical models
ICFO-The Institute of Photonic Sciences (Spain)
ESR 6
Time-gated diffuse optical spectroscopy for deep tissue diagnostics
Politecnico di Milano (Italy)
ESR 7
Multimodal nonlinear imaging for clinical diagnosis in combination with laser tissue ablation for selective tissue removal
Leibniz-Institute of Photonic Technology Jena (Germany)
ESR 8
Micro-optical imaging system for multimodal non-linear endospectroscopy
Grintech GmbH Jena (Germany)
ESR 9
Multimodal endo-microscopy for improved in-vivo colorectal cancer diagnosis
Albert-Ludwigs Universität Freiburg (Germany)
ESR 10
Multimodal intraoperative handheld forward-imaging probe
Medical University Vienna (Austria)
ESR 11
Towards multifunctional multimaterial optical fibres for diagnostic and treatment
Fondazione LINKS (Italy)
ESR 12
Development of advanced online dosimetry algorithms for photodynamic therapy of tumours
SpectraCure AB (Sweden)
ESR 13
Diffuse optical monitoring and prediction of neoadjuvant chemotherapy for personalized breast cancer management
Ospedale San Raffaele (Italy)
ESR 14
Tissue identification for surgical guidance using biophotonics
Tyndall National Institute, University College Cork (Ireland)
ESR 15
Micro-camera for hyperspectral imaging for in-vivo probing
Tyndall National Institute, University College Cork (Ireland)

Stay in touch

subscribe to our newsletter service

Subscribe

* indicates required

PHAST-ETN will use the information you provide on this form to be in touch with you and to provide updates and marketing.

By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.